Page 52 - TD-4-1

Tumor Discovery WDR4 in cancer

2022;15(1):63. novel biomarker promoting cancer cell proliferation in lung
adenocarcinoma. Front Oncol. 2022;12:1055605.
doi: 10.1186/s13045-022-01285-5
doi: 10.3389/fonc.2022.1055605
8. Cai M, Yang C, Wang Z. N7-methylguanosine modification:
From regulatory roles to therapeutic implications in cancer. 19. Duan HP, Yan JH, Nie L, Wang Y, Xie H. A noval prognostic
Am J Cancer Res. 2023;13(5):1640-1655. signature of the N7-methylguanosine (m7G)-related miRNA
in lung adenocarcinoma. BMC Pulm Med. 2023;23(1):14.
9. Du D, He J, Ju C, et al. When N -methyladenosine
7
modification meets cancer: Emerging frontiers and doi: 10.1186/s12890-022-02290-7
promising therapeutic opportunities. Cancer Lett. 20. Chen J, Li K, Chen J, et al. Aberrant translation regulated
2023;562:216165.
by METTL1/WDR4-mediated tRNA N7-methylguanosine
doi: 10.1016/j.canlet.2023.216165 modification drives head and neck squamous cell carcinoma
progression. Cancer Commun (Lond). 2022;42(3):223-244.
10. Wang YT, Chen RH. PML degradation fosters an
immunosuppressive and pro-metastatic tumor doi: 10.1002/cac2.12273
microenvironment. Mol Cell Oncol. 2017;4(6):e1364212.
21. Xu F, Cai D, Liu S, et al. N7-methylguanosine regulatory
doi: 10.1080/23723556.2017.1364212 genes well represented by METTL1 define vastly different
prognostic, immune and therapy landscapes in adrenocortical
11. Singh S, Yeat NY, Wang YT, et al. PTPN23 ubiquitination
by WDR4 suppresses EGFR and c-MET degradation to carcinoma. Am J Cancer Res. 2023;13(2):538-568.
define a lung cancer therapeutic target. Cell Death Dis. 22. Zhai Q, Hou Y, Ye Y, et al. Expression pattern and prognostic
2023;14(10):671. value of key regulators for N7-methylguanosine RNA
modification in prostate cancer. Acta Biochim Biophys Sin
doi: 10.1038/s41419-023-06201-4
(Shanghai). 2023;55(4):561-573.
12. Xia P, Zhang H, Xu K, et al. MYC-targeted WDR4 promotes
proliferation, metastasis, and sorafenib resistance by doi: 10.3724/abbs.2023017
inducing CCNB1 translation in hepatocellular carcinoma. 23. Mei W, Jia X, Xin S, et al. A N -methylguanine-related gene
7
Cell Death Dis. 2021;12(7):691. signature applicable for the prognosis and microenvironment
of prostate cancer. J Oncol. 2022;2022:8604216.
doi: 10.1038/s41419-021-03973-5
doi: 10.1155/2022/8604216
13. Wang YT, Chen J, Chang CW, et al. Ubiquitination of
7
tumor suppressor PML regulates prometastatic and 24. Han H, Yang C, Ma J, et al. N -methylguanosine tRNA
immunosuppressive tumor microenvironment. J Clin Invest. modification promotes esophageal squamous cell carcinoma
2017;127(8):2982-2997. tumorigenesis via the RPTOR/ULK1/autophagy axis. Nat
Commun. 2022;13(1):1478.
doi: 10.1172/JCI89957
doi: 10.1038/s41467-022-29125-7
14. Huang M, Long J, Yao Z, et al. METTL1-Mediated m7G
tRNA modification promotes lenvatinib resistance in 25. He S, Zhu J, Xiao Z, et al. WDR4 gene polymorphisms
hepatocellular carcinoma. Cancer Res. 2023;83(1):89-102. increase hepatoblastoma susceptibility in girls. J Cancer.
2022;13(12):3342-3347.
doi: 10.1158/0008-5472.CAN-22-0963
doi: 10.7150/jca.76255
15. Zhu S, Wu Y, Zhang X, et al. Targeting N -methylguanosine
7
tRNA modification blocks hepatocellular carcinoma 26. Deng L, Hua RX, Deng C, et al. WDR4 gene polymorphisms
metastasis after insufficient radiofrequency ablation. Mol and Wilms tumor susceptibility in Chinese children: A five-
Ther. 2023;31(6):1596-1614. center case-control study. J Cancer. 2023;14(8):1293-1300.
doi: 10.1016/j.ymthe.2022.08.004 doi: 10.7150/jca.83747
16. Dong R, Wang C, Tang B, et al. WDR4 promotes HCC 27. Jain BP, Pandey S. WD40 repeat proteins: Signalling scaffold
7
pathogenesis through N -methylguanosine by regulating with diverse functions. Protein J. 2018;37(5):391-406.
and interacting with METTL1. Cell Signal. 2024;118:111145.
doi: 10.1007/s10930-018-9785-7
doi: 10.1016/j.cellsig.2024.111145
28. Alexandrov A, Martzen MR, Phizicky EM. Two proteins
17. Ma J, Han H, Huang Y, et al. METTL1/WDR4-mediated that form a complex are required for 7-methylguanosine
m(7)G tRNA modifications and m(7)G codon usage modification of yeast tRNA. RNA. 2002;8(10):1253-1266.
promote mRNA translation and lung cancer progression. doi: 10.1017/s1355838202024019
Mol Ther. 2021;29(12):3422-3435.
29. Li J, Wang L, Hahn Q, et al. Structural basis of regulated
doi: 10.1016/j.ymthe.2021.08.005
m G tRNA modification by METTL1-WDR4. Nature.
7
18. Liu Y, Jiang B, Lin C, et al. m7G-related gene NUDT4 as a 2023;613(7943):391-397.

Volume 4 Issue 1 (2025) 44 doi: 10.36922/td.5830